4[4]American Thoracic Society Documents.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Crit Care Med,2005,171(4):388.
5[5]Rello J,Paiva JA,Baraibar J,et al.International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia[J].Chest,2001,120:955.
6[6]Sandiumenge A,Diaz E,Bodi M,et al.Therapy of ventilator-associated pneumonia:a patient-based approach based on the ten rules of "The Tarragona Strategy"[J].Intensive Care Med,2003,29:876.
6[3]Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associafed pneumona. [J]. Chest, 1997,111: 676
7[4]Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes:implications for the antibiotic management of ventilator-associated pneumonia. [J]. Chest, 1998,113:412
8[5]Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. [J]. Am J Respir Crit Car Med, 1997,156:196
10[7]George DL, Falk PSH RG. Epidemiology of ventilator-acquired pneumonia based onprotected bronchoscopic sampling. [J]. Am J Respir Crit Care Med 1998. 158:1839
